RxDoctor Payments Data

Sharon Richard, NP

Nurse Practitioner · Essex, MANPI 1821148479

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,712in general payments, 2019–2025

Across 16 payments — averaging $106.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$227
  • GSK$217
  • Madrigal Pharmaceuticals$150
  • Impulse Dynamics (USA) Inc.$122
  • Eisai Inc.$122
  • Boehringer Ingelheim$122
  • plus $753 from 8 others

What the payments were for

  • Food & beverage$1,712100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,712 in reported general payments places this provider in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$56,924
Medicare patients
274
Services billed
835

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$13,874
Atorvastatin Calcium95$1,223
Albuterol Sulfate HfaAlbuterol Sulfate30$823
Lisinopril83$599
Omeprazole33$526
Metoprolol Succinate32$411
Irbesartan12$409
Rosuvastatin Calcium17$360
Losartan Potassium40$342
Mirtazapine11$283
Amlodipine Besylate41$278
Famotidine20$238
Levothyroxine Sodium34$197
Hydrochlorothiazide26$149
Metformin Hcl13$146

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Essex

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →